Others pair NAD+ with IV vitamin therapy, B12 injections or amino acid injections
Our approach combines aesthetic and wellness treatments to help patients support energy, recovery, and long-term vitality
Protocol, Administration and Cost MIC is given intramuscularly, typically into the deltoid or gluteal muscle, most commonly weekly, sometimes twice weekly early in a programme
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body
Goal: Trigger short, pulsatile releases of the bodys own growth hormone via the GHS-R1a receptor [1] [2] downstream effects on muscle, fat or recovery are not established in controlled human trials